Showing 1311-1320 of 4307 results for "".
New NMSC Guidelines Highlight Options and Need for More Research
https://practicaldermatology.com/topics/practice-management/new-nmsc-guidelines-highlight-options-and-need-for-more-research/20544/The latest guidelines of care for SCC and BCC endorse the standard of care and show we need additional, high-quality research into non-surgical options.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sLaser Innovations on the Horizon
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-innovations-on-the-horizon/18534/Jill Waibel, MD discusses advances in lasers and what's on the horizon. She shares insights on a new and improved pulsed dye laser plus RF; fractional applications being investigated for scars, vitiligo, wrinkles, and more; plus devices for vaginal rejuvenation.Eyes Have It: Bloodless Blephs and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eyes-have-it-bloodless-blephs-and-more/18728/Demand for treatments around the eye continue to grow; patients want big results but little downtime. Dr. Niamtu discusses his "bloodless bleph" and other uses for fillers and toxins.PsO Many Options: The Expanded Psoriasis Landscape
https://practicaldermatology.com/topics/psoriasis/pso-many-options-the-expanded-psoriasis-landscape/18749/By Jeffrey Weinberg, MD and Seemal R. Desai, MDWith many new therapies coming out in oral, topical, and biologic forms, there are fewer unmet needs in psoriasis management now than ever before. Dr. Weinberg navigates the therapeutic landscape.Telemedicine and Access, Inappropriate Antibiotics, Industry Growth
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-telemedicine-and-access-inappropriate-antibiotics-industry-growth/18602/New research published online in JAMA Dermatology suggests that teledermatology improves access to care. Experts predict continued growth of telemedicine in dermatology. New estimates suggest that 30% of antibiotic prescriptions may be inappropriate. Dermatologists warn against antibiotic misuse andOnline Reputation Management Update
https://practicaldermatology.com/topics/practice-management/online-reputation-management-update/18658/Protecting your online reputation is crucial to your digital marketing success. If you think it's all about spotting and hiding bad reviews, you're wrong. Learn how to build and protect a stellar online reputation for your dermatology practice and how it will actually boost SEO. The Ekwa Marketing tReduce Burnout
https://practicaldermatology.com/topics/practice-management/reduce-burnout/21320/Riding the teeter-totter of a healthy work-life balance.Clinical Insights on Management of Comorbidities in the Psoriasis Patient
https://practicaldermatology.com/topics/psoriasis/clinical-insights-on-management-of-comorbidities-in-the-psoriasis-patient/21375/As psoriasis is associated with an increasing number of comorbidities, clinicians discuss their approach to management focused on the whole patient.Market Your Practice with Innovative Instagram and Vine Videos
https://practicaldermatology.com/topics/practice-management/market-your-practice-with-innovative-instagram-and-vine-videos/21407/When used creatively, Instagram or Vine videos can produce immensely successful marketing outcomes for your practice.